National Health Act 1953 Amendment determination under sections 85, 85a and 88 pharmaceutical benefits (No. PB 109 of 2008) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 109 of 2008

Amendment to the instrument that makes determinations under sections 85, 85A and 88 of the National Health Act 1953

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under section 85(6) of the National Health Act 1953.

Dated 3^rd NOVEMBER  2008

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination — pharmaceutical benefits

1              Commencement

This instrument commences at 11.59 pm on 30 November 2008.

2              Amendment of PB 75 of 2008

Schedule 1 amends PB 75 of 2008.

Schedule 1        Amendments

[1]       Part 1 of Schedule 1, item dealing with Risperidone

omit from the columns in the order indicated:

Oral solution 1 mg per mL, 30 mL Oral 1 2 Risperdal

[2]       Part 1 of Schedule 1, item dealing with Risperidone in the form Oral solution 1 mg per mL, 100 mL

omit from the column headed “Maximum number of repeats”:

5

and substitute:

2

[3]      Part 2 of Schedule 1, after the item dealing with Risperidone in the form Tablet 2 mg (orally disintegrating)

insert in the columns in the order indicated:

Oral solution 1 mg per mL, 100 mL	In compliance with authority procedures set out in subparagraph 11 (d):	Oral	1	5	Risperdal
1589	Schizophrenia
2272	Adjunctive therapy to mood stabilisers for up to 6 months, of an episode of acute mania associated with bipolar I disorder